← Open Payments lookup

KEITH LEMAY: Open Payments

NPI 1922379759 · SOUTH LAKE TAHOE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$660 in 27 payments from 15 companies in 2025. Trend: 2023 $158 · 2024 $315 · 2025 $660

Food & beverage: $660
CompanyPaymentsAmount
BridgeBio Pharma, Inc.1$138
Novartis Pharmaceuticals Corporation3$86
GlaxoSmithKline, LLC.4$77
PFIZER INC.3$57
Astellas Pharma US Inc3$48
Otsuka America Pharmaceutical, Inc.2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Edwards Lifesciences Corporation1$33
Lilly USA, LLC2$30
ABBVIE INC.1$23

Products named: Attruby, LEQVIO, TRELEGY ELLIPTA, PREVNAR 20, Veozah, REXULTI, CAPLYTA, SAPIEN 3 Ultra RESILIA.

Industry payments across CA — which companies pay providers there.